Swarthmore, PA, United States of America

Raluca I Verona

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Swarthmore, PA (US) (2023)
  • Spring House, PA (US) (2021 - 2024)

Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Raluca I Verona: Innovator in Cancer Treatment

Introduction

Raluca I Verona is a prominent inventor based in Swarthmore, PA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of antibodies. With a total of 5 patents to her name, Raluca has established herself as a key figure in biotechnology.

Latest Patents

Raluca's latest patents include groundbreaking work on antibodies specifically binding PD-1, TIM-3, or both PD-1 and TIM-3. This invention relates to the development of antibodies, polynucleotides encoding these antibodies or fragments, and methods for their production and application. Additionally, she has disclosed methods for treating cancers and enhancing the efficacy of BCMAxCD3 bispecific antibodies. These methods involve the use of BCMAxCD3 bispecific antibodies, anti-CD38 antibodies, and/or pomalidomide to treat cancers, particularly relapsed or refractory multiple myeloma.

Career Highlights

Raluca is currently employed at Janssen Biotech, Inc., where she continues to push the boundaries of cancer research. Her work has been instrumental in developing therapies that improve patient outcomes and advance the field of oncology.

Collaborations

Some of Raluca's notable coworkers include Gordon Powers and Nina Chi Sabins, who contribute to her innovative projects and research initiatives.

Conclusion

Raluca I Verona's contributions to cancer treatment through her patents and research at Janssen Biotech, Inc. highlight her role as a leading inventor in the biotechnology field. Her work continues to inspire advancements in medical science and improve the lives of patients battling cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…